None listed
Conditions
Interventions
Participants will be randomised into one of four treatment groups & given a supplement containing either; selenium, iodine, selenium & iodine or placebo. Participants take one supplement daily for 12 weeks. Selenium, iodine and thryoid status of participants will be measured at 5 time point over the intervention.
Sponsors
University of Otago, Dunedin, New Zealand
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)
Eligibility
Sex/Gender
All
Age
65 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
Plasma Selenium <100ugLPersons not institutionalisedAmbulatoryGood Health with no serious medical illnesses
Exclusion criteria
Institutionalised. Plasma Se >100ugL. Serious Medical Illness
Outcome results
None listed